Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 7
1990 2
1991 2
1993 6
1994 6
1995 8
1996 3
1997 4
1998 9
1999 7
2000 7
2001 2
2002 5
2003 5
2004 5
2005 8
2006 7
2007 14
2008 11
2009 9
2010 11
2011 7
2012 6
2013 7
2014 11
2015 6
2016 11
2017 13
2018 11
2019 9
2020 14
2021 14
2022 5
2023 8
2024 8
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

247 results

Results by year

Filters applied: . Clear all
Page 1
Recherche translationnelle : médecine personnalisée, médecine de précision, thérapies ciblées : marketing ou science ?
Marquet P, Longeray PH, Barlesi F; les participants à la table ronde N°1 de Giens XXX :; Ameye V, Augé P, Cazeneuve B, Chatelut E, Diaz I, Diviné M, Froguel P, Goni S, Gueyffier F, Hoog-Labouret N, Mourah S, Morin-Surroca M, Perche O, Perin-Dureau F, Pigeon M, Tisseau A, Verstuyft C. Marquet P, et al. Among authors: chatelut e. Therapie. 2015 Jan-Feb;70(1):1-10. doi: 10.2515/therapie/2014230. Therapie. 2015. PMID: 27393393 French. No abstract available.
[Therapeutic drug monitoring].
Le Guellec C, Bentué-Ferrer D; groupe STP de la SFPT. Le Guellec C, et al. Therapie. 2010 Jan-Feb;65(1):13-5. Therapie. 2010. PMID: 20443240 French. No abstract available.
Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib.
Puszkiel A, Noé G, Bellesoeur A, Kramkimel N, Paludetto MN, Thomas-Schoemann A, Vidal M, Goldwasser F, Chatelut E, Blanchet B. Puszkiel A, et al. Among authors: chatelut e. Clin Pharmacokinet. 2019 Apr;58(4):451-467. doi: 10.1007/s40262-018-0703-0. Clin Pharmacokinet. 2019. PMID: 30094711 Review.
Niveau de preuve du suivi thérapeutique pharmacologique du carboplatine.
Hulin A, Chatelut E, Royer B, Le Guellec C; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Hulin A, et al. Among authors: chatelut e. Therapie. 2010 May-Jun;65(3):157-62. doi: 10.2515/therapie/2010021. Therapie. 2010. PMID: 27392981 French.
Niveau de preuve du suivi thérapeutique pharmacologique du cisplatine.
Hulin A, Royer B, Chatelut E, Le Guellec C; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Hulin A, et al. Among authors: chatelut e. Therapie. 2010 May-Jun;65(3):151-5. doi: 10.2515/therapie/2010022. Therapie. 2010. PMID: 27392980 French.
New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid.
Heldrup J, Bleyer A, Ramsey L, Schaff L, Bernhardt B, Schwartz S, Chatelut E, Hwang M, Ten C, Guscott M, Howard S. Heldrup J, et al. Among authors: chatelut e. Cancer Chemother Pharmacol. 2025 Mar 13;95(1):41. doi: 10.1007/s00280-025-04749-w. Cancer Chemother Pharmacol. 2025. Retraction in: Cancer Chemother Pharmacol. 2025 Jul 25;95(1):77. doi: 10.1007/s00280-025-04798-1. PMID: 40075030 Free PMC article. Retracted. Review.
Toxicity patterns of cytotoxic drugs.
Chatelut E, Delord JP, Canal P. Chatelut E, et al. Invest New Drugs. 2003 May;21(2):141-8. doi: 10.1023/a:1023565227808. Invest New Drugs. 2003. PMID: 12889735 Review.
247 results